DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) — DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX-V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering…

About Globe Newswire

Nasdaq Globenewswire on NEWSTAGE
View all posts by Globe Newswire →

Leave a Reply

Your email address will not be published. Required fields are marked *